www.fdanews.com/articles/62228-pfizer-wins-norvasc-patent-challenge-by-generic-manufacturer-synthon
PFIZER WINS NORVASC PATENT CHALLENGE BY GENERIC MANUFACTURER SYNTHON
September 1, 2006
Pfizer Inc said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension. The patent had been challenged by the generic manufacturer, Synthon
Pharmaceuticals.
Yahoo
Finance